Myeloid Beta-Arrestin 2 Depletion Alleviates Metabolic Dysfunction-Associated Steatohepatitis through Metabolic Reprogramming of Macrophages
The Loss of β-arrestin 2 in Hepatic Macrophages Alleviates Metabolic Dysfunction-associated Steatohepatitis — Through Metabolic Reprogramming of Macrophages Background and Motivation Metabolic dysfunction-associated fatty liver disease (MASLD) is a globally prevalent health issue, affecting approximately 25% of the population. This disease includes...